CONFORM pivotal trial negative_blue RGB

CLAAS System IFU Rev. L

22July2025

Protocol Rev. R

18Feb2026

Protocol Synopsis Rev. R

18Feb2026

Memos to File

CONFORM Study -Use of Electronic Informed Consent (eConsent)

05Dec2025

CONFORM Study – Pre-Discharge TTE

05Dec2025

CONFORM Study -Verbal Informed Consent

05Dec2025

CONFORM Study Pre-Randomization Screen Failures

03March2026
I/E Card

Inclusion / Exclusion Criteria Card Protocol Rev. R

For The CONFORM Pivotal Trial with The CLAAS® AcuFORM™ Device 

24Apr2026

Download Print File Here

Redline Protocol and Summary of Changes

Protocol Rev M to R redlines

CONFORM Protocol Summary of Changes V13

CAUTION: Investigational Device
Limited by federal (or United States) law to investigational use. Outside the United States, the device is intended exclusively for clinical investigation. Not approved for commercial use.